{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:20:31Z","timestamp":1788618031718,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"am","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejso.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T12:59:07Z","timestamp":1662728347000},"page":"368-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-9258","authenticated-orcid":false,"given":"Shinsuke","family":"Nagasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-9091","authenticated-orcid":false,"given":"Sho","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6858-3420","authenticated-orcid":false,"given":"Yasushi","family":"Rino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0843-8766","authenticated-orcid":false,"given":"Chikara","family":"Kunisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.09.003_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2022.09.003_bib2","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.09.003_bib3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (Classic): 5-year follow-up of an open-label, randomised phase 3 trial","volume":"15","author":"Noh","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.09.003_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10120-017-0767-9","article-title":"Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?","volume":"21","author":"Fujitani","year":"2018","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.09.003_bib5","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1245\/s10434-020-09504-4","article-title":"Appropriate number of adjuvant chemotherapy cycles for patients with Stage 2 or 3 gastric cancer after curative gastrectomy: a multicenter cohort study","volume":"28","author":"Jeong","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.09.003_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2468-1253(18)30383-2","article-title":"Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial","volume":"4","author":"Yoshikawa","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2022.09.003_bib7","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2776-6","article-title":"Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer","volume":"20","author":"Aoyama","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.09.003_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1200\/JCO.2021.39.3_suppl.196","article-title":"Risk factors for the continuation of S-1 adjuvant chemotherapy for gastric cancer analyzed from the JCOG1104 phase III trial","volume":"39","author":"Yamada","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.09.003_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/03071022.2017.1256093","article-title":"The rise of living alone and loneliness in history","volume":"42","author":"Snell","year":"2017","journal-title":"Soc Hist"},{"key":"10.1016\/j.ejso.2022.09.003_bib10","series-title":"Annual report on the","author":"Office","year":"2013"},{"key":"10.1016\/j.ejso.2022.09.003_bib11","series-title":"World report on ageing and health","first-page":"246","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ejso.2022.09.003_bib12","first-page":"92","article-title":"The effect of loneliness on malnutrition in elderly population","volume":"65","author":"Ramic","year":"2011","journal-title":"Med Arh"},{"key":"10.1016\/j.ejso.2022.09.003_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10120-011-0040-6","article-title":"New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points","volume":"14","author":"Sano","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.09.003_bib14","series-title":"TNM classification of malignant tumours","author":"Sobin","year":"2017"},{"key":"10.1016\/j.ejso.2022.09.003_bib15","first-page":"1","article-title":"Japanese gastric cancer treatment guidelines","volume":"24","year":"2018","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.09.003_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.09.003_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1245\/s10434-018-7063-8","article-title":"Survival outcomes of two Phase 2 studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin for patients with gastric cancer after D2 gastrectomy","volume":"26","author":"Nakamura","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.09.003_bib18","series-title":"Common terminology criteria for adverse events (CTCAE). version 4.0","first-page":"4","author":"Health Udo","year":"2009"},{"key":"10.1016\/j.ejso.2022.09.003_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083196","article-title":"Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer","volume":"8","author":"Qu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejso.2022.09.003_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/nu12030737","article-title":"Social and economic factors and malnutrition or the risk of malnutrition in the elderly: a systematic review and meta-analysis of observational studies","volume":"12","author":"Besora-Moreno","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ejso.2022.09.003_bib21","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2022.09.003_bib22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<796::AID-CNCR10>3.0.CO;2-P","article-title":"The predictive value of body protein for chemotherapy-induced toxicity","volume":"88","author":"Aslani","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.09.003_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.janxdis.2013.03.010","article-title":"The role of social isolation in social anxiety disorder: a systematic review and meta-analysis","volume":"27","author":"Teo","year":"2013","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.ejso.2022.09.003_bib24","article-title":"Vivre seul ou en couple: quelle influence sur la satisfaction de la vie des hommes et des femmes \u00e2g\u00e9s en Europe?","volume":"45\u201374","author":"Gaymu","year":"2012","journal-title":"Population"},{"key":"10.1016\/j.ejso.2022.09.003_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1525-1497.2000.06139.x","article-title":"Problems of older adults living alone after hospitalization","volume":"15","author":"Mahoney","year":"2000","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ejso.2022.09.003_bib26","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s10120-019-00953-9","article-title":"Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy","volume":"22","author":"Takahashi","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2022.09.003_bib27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1200\/JCO.18.01138","article-title":"Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with Stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial","volume":"37","author":"Yoshida","year":"2019","journal-title":"J\u00a0Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322006540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:46:27Z","timestamp":1760060787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322006540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0748798322006540"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.09.003","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}